Article
Pharmacogenetics in the Treatment of Huntington’s Disease: Review and Future Perspectives
22 Feb 2023
Abstract excerpt
Huntington's disease (HD) is an autosomal dominant progressive brain disorder, caused by a pathological expansion of a CAG repeat that encodes the huntingtin gene. This genetic neurodegenerative rare disease is characterized by cognitive, motor, and neuropsychiatric manifestations. The aim of the treatment is symptomatic and addresses the hyperkinetic disorders (chorea, dystonia, myoclonus, tics, etc.) and the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
